Jo E. Rodgers

2.7k total citations
67 papers, 1.4k citations indexed

About

Jo E. Rodgers is a scholar working on Cardiology and Cardiovascular Medicine, Family Practice and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Jo E. Rodgers has authored 67 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Cardiology and Cardiovascular Medicine, 10 papers in Family Practice and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Jo E. Rodgers's work include Heart Failure Treatment and Management (29 papers), Cardiovascular Function and Risk Factors (10 papers) and Medication Adherence and Compliance (9 papers). Jo E. Rodgers is often cited by papers focused on Heart Failure Treatment and Management (29 papers), Cardiovascular Function and Risk Factors (10 papers) and Medication Adherence and Compliance (9 papers). Jo E. Rodgers collaborates with scholars based in United States, Saudi Arabia and Spain. Jo E. Rodgers's co-authors include Julia Khanova, Jacqueline E. McLaughlin, Mary T. Roth, J. Herbert Patterson, Sally C. Stearns, Khalid A. Alburikan, Stacy Campbell-Bright, Shannon S. Carson, John P. Kress and Steven P. Dunn and has published in prestigious journals such as Journal of the American College of Cardiology, PLoS ONE and The American Journal of Medicine.

In The Last Decade

Jo E. Rodgers

63 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jo E. Rodgers United States 20 580 251 205 195 167 67 1.4k
Susan Gallagher United States 14 301 0.5× 217 0.9× 624 3.0× 23 0.1× 126 0.8× 67 1.4k
Aaron Conway Australia 16 410 0.7× 172 0.7× 184 0.9× 20 0.1× 103 0.6× 70 1.1k
Emmae Ramsay Australia 24 285 0.5× 47 0.2× 52 0.3× 11 0.1× 113 0.7× 55 1.6k
Dale Rublee United States 19 296 0.5× 40 0.2× 271 1.3× 6 0.0× 95 0.6× 37 1.6k
Vikas Saini United States 13 111 0.2× 46 0.2× 74 0.4× 12 0.1× 46 0.3× 20 1.7k
David W. Rudy United States 16 207 0.4× 18 0.1× 24 0.1× 48 0.2× 184 1.1× 28 1.1k
Barbara S. Wiggins United States 15 761 1.3× 58 0.2× 18 0.1× 8 0.0× 89 0.5× 40 1.8k
Elisabeth George United Kingdom 18 112 0.2× 275 1.1× 144 0.7× 7 0.0× 142 0.9× 66 1.3k
Paul J. Hauptman United States 24 1.2k 2.0× 62 0.2× 36 0.2× 6 0.0× 583 3.5× 57 2.4k
Renée A. Stiles United States 13 326 0.6× 1.5k 5.9× 1.2k 5.8× 5 0.0× 145 0.9× 19 2.3k

Countries citing papers authored by Jo E. Rodgers

Since Specialization
Citations

This map shows the geographic impact of Jo E. Rodgers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jo E. Rodgers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jo E. Rodgers more than expected).

Fields of papers citing papers by Jo E. Rodgers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jo E. Rodgers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jo E. Rodgers. The network helps show where Jo E. Rodgers may publish in the future.

Co-authorship network of co-authors of Jo E. Rodgers

This figure shows the co-authorship network connecting the top 25 collaborators of Jo E. Rodgers. A scholar is included among the top collaborators of Jo E. Rodgers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jo E. Rodgers. Jo E. Rodgers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vest, Amanda R., Philip R. Schauer, Jo E. Rodgers, et al.. (2024). Obesity and Weight Loss Strategies for Patients With Heart Failure. JACC Heart Failure. 12(9). 1509–1527. 8 indexed citations
2.
Casey, Martin F., et al.. (2024). Emergency Department Use of Heart Failure-Exacerbating Medications in Patients with Chronic Heart Failure. Drug Safety. 47(12). 1225–1234.
3.
Bloom, Michelle, Jo E. Rodgers, Alessandra Ferrari, et al.. (2024). Cardio-Oncology and Heart Failure: AL Amyloidosis for the Heart Failure Clinician: a Supplement to the Scientific Statement from the Heart Failure Society of America. Journal of Cardiac Failure. 31(2). 456–463. 1 indexed citations
4.
Almangour, Thamer A., et al.. (2023). Heart transplantation and human immunodeficiency virus–navigating drug-drug interactions: a case report. AIDS Research and Therapy. 20(1). 55–55.
5.
Holger, Dana, et al.. (2022). Post‐graduate pharmacy fellowships: The current state of affairs. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 6(2). 145–153. 1 indexed citations
6.
Meyer, Michelle L., et al.. (2022). Accuracy of the electronic health record’s problem list in describing multimorbidity in patients with heart failure in the emergency department. PLoS ONE. 17(12). e0279033–e0279033. 3 indexed citations
7.
8.
Cook, Abigail, et al.. (2018). A case‐control study of the risk factors for developing aspergillosis following cardiac transplant. Clinical Transplantation. 32(9). e13367–e13367. 5 indexed citations
9.
Caughey, Melissa C., Sally C. Stearns, Amil M. Shah, et al.. (2017). READMISSIONS FOR PATIENTS DISCHARGED WITH ACUTE DECOMPENSATED HEART FAILURE AND REDUCED VERSUS PRESERVED EJECTION FRACTION: THE ATHEROSCLEROSIS RISK IN COMMUNITIES STUDY. Journal of the American College of Cardiology. 69(11). 775–775. 1 indexed citations
10.
Tran, Richard, Patricia P. Chang, Carla A. Sueta, et al.. (2016). MORTALITY FOLLOWING INITIATION OR DISCONTINUATION OF GUIDELINE DIRECTED MEDICAL THERAPIES IN HOSPITALIZED HEART FAILURE PATIENTS IN THE ATHEROSCLEROSIS RISK IN COMMUNITIES STUDY. Journal of the American College of Cardiology. 67(13). 1549–1549. 1 indexed citations
11.
Sueta, Carla A., Jo E. Rodgers, Patricia P. Chang, et al.. (2015). Medication Adherence Based on Part D Claims for Patients With Heart Failure After Hospitalization (from the Atherosclerosis Risk in Communities Study). The American Journal of Cardiology. 116(3). 413–419. 28 indexed citations
12.
McLaughlin, Jacqueline E., et al.. (2015). The Impact of Blended Learning on Student Performance in a Cardiovascular Pharmacotherapy Course. American Journal of Pharmaceutical Education. 79(2). 24–24. 44 indexed citations
13.
Thomson, Margaret R., et al.. (2010). Continuous Versus Intermittent Infusion of Furosemide in Acute Decompensated Heart Failure. Journal of Cardiac Failure. 16(3). 188–193. 68 indexed citations
14.
Crespo, Eric M., Gustavo B.F. Oliveira, Emily Honeycutt, et al.. (2009). Evaluation and management of thrombocytopenia and suspected heparin-induced thrombocytopenia in hospitalized patients: The Complications After Thrombocytopenia Caused by Heparin (CATCH) registry. American Heart Journal. 157(4). 651–657. 35 indexed citations
15.
Cox, Christopher E., Shelby D. Reed, Joseph A. Govert, et al.. (2008). Economic evaluation of propofol and lorazepam for critically ill patients undergoing mechanical ventilation*. Critical Care Medicine. 36(3). 706–714. 33 indexed citations
16.
Carson, Shannon S., John P. Kress, Jo E. Rodgers, et al.. (2006). A randomized trial of intermittent lorazepam versus propofol with daily interruption in mechanically ventilated patients*. Critical Care Medicine. 34(5). 1326–1332. 200 indexed citations
17.
Dorsch, Michael P. & Jo E. Rodgers. (2006). Nesiritide: Harmful or Harmless?. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 26(10). 1465–1478. 3 indexed citations
18.
Dorsch, Michael P., et al.. (2006). Abciximab‐Associated Thrombocytopenia After Previous Tirofiban‐Related Thrombocytopenia. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 26(3). 423–427. 4 indexed citations
19.
Rodgers, Jo E. & J. Herbert Patterson. (2000). The Role of the Renin‐Angiotensin‐Aldosterone System in the Management of Heart Failure. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 20(11P2). 368S–378S. 6 indexed citations
20.
Rodgers, Jo E., et al.. (1998). Prolonged weakness after cisatracurium infusion. Critical Care Medicine. 26(7). 1290–1292. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susan Gallagher Breakdown of academic impact, for papers by Aaron Conway Breakdown of academic impact, for papers by Emmae Ramsay Breakdown of academic impact, for papers by Dale Rublee Breakdown of academic impact, for papers by Vikas Saini Breakdown of academic impact, for papers by David W. Rudy Breakdown of academic impact, for papers by Barbara S. Wiggins Breakdown of academic impact, for papers by Elisabeth George Breakdown of academic impact, for papers by Paul J. Hauptman Breakdown of academic impact, for papers by Renée A. Stiles
Rankless by CCL
2026